benefit from both beta-blockade and ACE inhibition. However, his blood pressure was typically only 110/70 mm Hg, so only one agent could be administered, and given the frequent ventricular ectopy, his doctors elected to treat with a low dose of metoprolol succinate. Dudzinski and Schrager ask readers to keep in mind the varied presentations of polyarteritis nodosa. A more exhaustive differential diagnosis for this patient would include polyarteritis nodosa, since it can result in both renal and myocardial infarction. However, this patient had no cutaneous lesions or neuropathy,3 had sinus bradycardia rather than tachycardia, and was found on angiography to have only a subtle irregularity of the midportion of the left anterior descending coronary artery; there was no evidence of aneurysms, obstruction, nodularity, dissection, or thrombosis, which would suggest polyarteritis nodosa. Moreover, since the left
ventricular apical aneurysm did not appear to be consistent with a myocardial infarction, it seemed unlikely that the aneurysm was the result of vasculitis or other pathology of the coronary artery. Therefore, although the diagnosis of polyarteritis nodosa could not be formally excluded, it seemed insufficiently likely to warrant discussion, particularly in view of the limited space available in the article. Eric M. Isselbacher, M.D.
Massachusetts General Hospital Boston, MA Since publication of the article, the author reports no further potential conflict of interest.
1. Rassi A Jr, Rassi A, Little WC, et al. Development and valida-
tion of a risk score for predicting death in Chagas heart disease. N Engl J Med 2006;355:799-808. 2. Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 2007;115:1101-8. 3. Stone JH. Polyarteritis nodosa. JAMA 2002;288:1632-9.
The New England Journal of Medicine Downloaded from nejm.org on February 28, 2014. For personal use only. No other uses without permission. Copyright 2010 Massachusetts Medical Society. All rights reserved.
notices
the hydrolysis of glucosinolates; the cooking BLeedING aNd THrOMbOSING DISeaSeS: 2010 MaYO UPdate process largely deactivates the myrosinase in The Coagulation Conference and Wet Workshop will be 3 these vegetables. This case demonstrates the held in Rochester, MN, Aug. 36. Contact Diane Strain, Mayo Medical Laboratories, 3050 Supotential for nutritional factors to have a properior Dr. NW, Rochester, MN 55901; or call (507) 284-0286; found effect on health. or see http://www.mayomedicallaboratories.com/education/ coag2010; or e-mail strain.diane@mayo.edu. Michael Chu, M.D. Terry F. Seltzer, M.D.
New York University School of Medicine New York, NY michael.chu@nyumc.org Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.
1. Chesney AM, Clawson TA, Webster B. Endemic goiter in rab-
The symposium will be held in Rio de Janeiro, Aug. 2427. Contact Sabin Vaccine Institute, 2000 Pennsylvania Ave. NW, Suite 7100, Washington, DC 20006; or call (202) 842-5025; or fax (202) 842-7689; or see http://www.smallpox2010.org.
bits. Bull Johns Hopkins Hosp 1928;43:261. 2. Astwood EB, Greer MA, Ettlinger MG. 1-5-Vinyl-2-thiooxazolidone, an antithyroid compound from yellow turnip and from Brassica seeds. J Biol Chem 1949;181:121-30. 3. Dekker M, Verkerk R, Jongen WM. Predictive modelling of health aspects in the food production chain: a case study on glucosinolates in cabbage. Trends Food Sci 2000;11:174-81.
Correspondence Copyright 2010 Massachusetts Medical Society.
Letters to the Editor are considered for publication, subject to editing and abridgment, provided they do not contain material that has been submitted or published elsewhere. Please note the following: Letters in reference to a Journal article must not exceed 175 words (excluding references) and must be received within 3 weeks after publication of the article. Letters not related to a Journal article must not exceed 400 words. A letter can have no more than five references and one figure or table. A letter can be signed by no more than three authors. Financial associations or other possible conflicts of interest must be disclosed. Disclosures will be published with the letters. (For authors of Journal articles who are responding to letters, disclosures appear in the published articles.) Include your full mailing address, telephone number, fax number, and e-mail address with your letter. All letters must be submitted at authors.NEJM.org. We cannot acknowledge receipt of your letter, but we will notify you when we have made a decision about publication. Letters that do not adhere to these instructions will not be considered. Rejected letters and figures will not be returned. We are unable to provide prepublication proofs. Submission of a letter constitutes permission for the Massachusetts Medical Society, its licensees, and its assignees to use it in the Journals various print and electronic publications and in collections, revisions, and any other form or medium.
notices
Notices submitted for publication should contain a mailing address and telephone number of a contact person or department. We regret that we are unable to publish all notices received. Notices also appear on the Journals Web site (NEJM.org/meetings). The listings can be viewed in their entirety or searched by location, month, or key word.
1946
For letters to the Editor: authors.NEJM.org For information about the status of a submitted manuscript: authors.NEJM.org To submit a meeting notice: meetingnotices@NEJM.org The Journals Web pages: NEJM.org
The New England Journal of Medicine Downloaded from nejm.org on February 28, 2014. For personal use only. No other uses without permission. Copyright 2010 Massachusetts Medical Society. All rights reserved.